Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

A genomic-led strategy to anticipate drug safety effects

Submitted by Anna Hakala on Mon, 10/06/2025 - 14:44
  • Read more about A genomic-led strategy to anticipate drug safety effects

Expanded map of genomic imprinting reveals insight into human disease

Submitted by Anna Hakala on Mon, 10/06/2025 - 14:37
  • Read more about Expanded map of genomic imprinting reveals insight into human disease

Germline Variants Influence Chronic Liver Disease Progression through Distinct Pathways

Submitted by Anna Hakala on Mon, 10/06/2025 - 14:36
  • Read more about Germline Variants Influence Chronic Liver Disease Progression through Distinct Pathways

The Genetics of Fibromyalgia and its Relationships to Psychiatric and Medical Traits

Submitted by Anna Hakala on Mon, 10/06/2025 - 14:34
  • Read more about The Genetics of Fibromyalgia and its Relationships to Psychiatric and Medical Traits

Triangulating cross-carcinoma GWAS delineates shared programs and disease-specific drivers

Submitted by Anna Hakala on Mon, 10/06/2025 - 14:33
  • Read more about Triangulating cross-carcinoma GWAS delineates shared programs and disease-specific drivers

Genetic liability to meniscus degeneration and its comorbidity patterns: a phenome-wide association study in the UK Biobank

Submitted by Anna Hakala on Mon, 10/06/2025 - 14:32
  • Read more about Genetic liability to meniscus degeneration and its comorbidity patterns: a phenome-wide association study in the UK Biobank

The protective PLCG2 variants delay Alzheimer’s disease onset age in APOE ε4 carriers

Submitted by Anna Hakala on Mon, 10/06/2025 - 14:31
  • Read more about The protective PLCG2 variants delay Alzheimer’s disease onset age in APOE ε4 carriers

Mendelian randomization to inform a clinical trial of chitotriosidase inhibition for pulmonary sarcoidosis

Submitted by Anna Hakala on Mon, 10/06/2025 - 14:27
  • Read more about Mendelian randomization to inform a clinical trial of chitotriosidase inhibition for pulmonary sarcoidosis

Genetic predisposition to high BMI and changes in BMI during adolescence modulate associations between adult BMI and plasma molecules involved in glucose metabolism

Submitted by Anna Hakala on Mon, 10/06/2025 - 14:25
  • Read more about Genetic predisposition to high BMI and changes in BMI during adolescence modulate associations between adult BMI and plasma molecules involved in glucose metabolism

Multi-ancestry genome-wide and transcriptome-wide association analyses identified new risk loci and genes for inflammatory bowel disease

Submitted by Anna Hakala on Mon, 10/06/2025 - 14:16
  • Read more about Multi-ancestry genome-wide and transcriptome-wide association analyses identified new risk loci and genes for inflammatory bowel disease

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 52
  • Page 53
  • Page 54
  • Page 55
  • Current page 56
  • Page 57
  • Page 58
  • Page 59
  • Page 60
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement